Výsledky vyhledávání - "Kristen Ibanez"

Akademický článek

The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial

Autor: Elena Giudice, Tzu-Ting Huang, Jayakumar R. Nair, Grant Zurcher, Ann McCoy, Darryl Nousome, Marc R. Radke, Elizabeth M. Swisher, Stanley Lipkowitz, Kristen Ibanez, Duncan Donohue, Tyler Malys, Min-Jung Lee, Bernadette Redd, Elliot Levy, Shraddha Rastogi, Nahoko Sato, Jane B. Trepel, Jung-Min Lee

Publikováno v: Nature Communications, Vol 15, Iss 1, Pp 1-14 (2024)

Abstract The multi-cohort phase 2 trial NCT02203513 was designed to evaluate the clinical activity of the CHK1 inhibitor (CHK1i) prexasertib in patients with breast or ovarian cancer. Here we report the activity of CHK1i in platinum-resistant high-gr

Externí odkaz: https://doaj.org/article/a32a2dc2018942d5a1dda8aa8f8851d8

Zobrazit plný text záznamu

Periodical

Research Reports on Gynecologic Cancer from National Cancer Institute (NCI) Provide New Insights (Abstract C164: Underrepresentation of Black and elderly populations in immunotherapy-based clinical trials for gynecologic cancers: Trends over...).

Publikováno v: Cancer Vaccine Week; 10/7/2024, p90-90, 1p

Zobrazit plný text záznamu

Akademický článek

The CHK1 inhibitor prexasertib in BRCA wildtype platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial.

Autor: Giudice, Elena, Tzu-Ting Huang, Nair, Jayakumar R., Zurcher, Grant, McCoy, Ann, Nousome, Darryl, Radke, Marc R., Swisher, Elizabeth M., Lipkowitz, Stanley, Ibanez, Kristen, Donohue, Duncan, Malys, Tyler, Redd, Bernadette, Levy, Elliot, Rastogi, Shraddha, Sato, Nahoko, Trepel, Jane B., Jung-Min Lee

Publikováno v: Nature Communications; 3/30/2024, Vol. 15 Issue 1, p1-14, 14p, 16 Graphs

Zobrazit plný text záznamu

Periodical

Study Findings from University of Central Florida Provide New Insights into Pediatrics (No Value Found With Routine Early Postoperative Radiographs After Implant Removal In Pediatric Patients).

Publikováno v: Pediatrics Week; 8/23/2024, p547-547, 1p

Zobrazit plný text záznamu

Periodical

Research from National Cancer Institute (NCI) in the Area of Ovarian Cancer Described (The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial).

Publikováno v: Women's Health Weekly; 4/15/2024, p1183-1183, 1p

Zobrazit plný text záznamu